| Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas (NCT02186509) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-01-30 |
| Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas (NCT02015819) | City of Hope Medical Center | 2014-10-07 |
| Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors (NCT02194452) | Sue O'Dorisio | 2013-09-01 |
| Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme (NCT01648348) | National Cancer Institute (NCI) | 2012-11-01 |
| Carboplatin in Treating Patients With Recurrent High-Grade Gliomas (NCT01644955) | James Elder | 2012-06-11 |
| High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma (NCT01378481) | National Cancer Institute (NCI) | 2012-06-01 |
| 3T MRI Biomarkers of Glioma Treatment Response (NCT01996527) | Vanderbilt-Ingram Cancer Center | 2012-05-01 |
| Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases (NCT02967380) | University of Southern California | 2011-12-14 |
| Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas (NCT01478321) | Northwestern University | 2011-12-14 |
| RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma (NCT01189240) | National Cancer Institute (NCI) | 2010-12-01 |
| Yoga Therapy in Treating Patients With Malignant Brain Tumors (NCT01234805) | Wake Forest University Health Sciences | 2010-12-01 |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases (NCT01234740) | City of Hope Medical Center | 2010-12-01 |
| A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas (NCT01172964) | City of Hope Medical Center | 2010-08-01 |
| Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma (NCT01165632) | Mayo Clinic | 2010-07-26 |
| Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors (NCT01148966) | University of Washington | 2010-06-01 |
| Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma (NCT01103375) | Wake Forest University Health Sciences | 2010-05-01 |
| Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors (NCT01131234) | National Cancer Institute (NCI) | 2010-05-01 |
| RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma (NCT01119599) | National Cancer Institute (NCI) | 2010-05-01 |
| Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma (NCT01051557) | National Cancer Institute (NCI) | 2010-01-27 |
| Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma (NCT00823797) | University of Washington | 2008-10-01 |
| Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma (NCT00650923) | National Cancer Institute (NCI) | 2008-07-01 |
| Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer (NCT00492089) | National Cancer Institute (NCI) | 2007-06-01 |
| Sunitinib in Treating Patients With Recurrent Malignant Gliomas (NCT00499473) | National Cancer Institute (NCI) | 2007-06-01 |
| VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide (NCT00369590) | National Cancer Institute (NCI) | 2006-08-01 |
| Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas (NCT00268385) | National Cancer Institute (NCI) | 2005-12-16 |
| Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors (NCT00110032) | National Cancer Institute (NCI) | 2005-06-01 |
| Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma (NCT00112736) | National Cancer Institute (NCI) | 2005-04-01 |
| FR901228 in Treating Patients With Recurrent High-Grade Gliomas (NCT00085540) | National Cancer Institute (NCI) | 2005-01-01 |
| Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma (NCT00093613) | National Cancer Institute (NCI) | 2004-12-01 |
| A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas (NCT00045708) | National Cancer Institute (NCI) | 2002-10-01 |
| Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma (NCT00045110) | National Cancer Institute (NCI) | 2002-08-01 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498) | National Cancer Institute (NCI) | 2001-12-01 |
| Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma (NCT00430079) | National Cancer Institute (NCI) | 2001-07-01 |
| Bortezomib in Treating Patients With Recurrent Glioma (NCT00006773) | National Cancer Institute (NCI) | 2001-05-01 |
| Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas (NCT02055196) | City of Hope Medical Center | |